Aptorum Group Limited - APM Earnings growth forecast for next year
Aptorum Group Limited operations are independent of economic cycles, as biotech success is determined by trial results. Analyst expectations for N+1 profit dynamics provided by the GURU.Markets system confirm this, while the 0.00 indicator determines the metric's magnitude. Stability is ensured by streamlined raw material supply chains and a diversified development portfolio in oncology and infectious diseases, which mitigates investment risks.
Metric breakdowns and analytics for Aptorum Group (APM)
- price and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- debt and liquidity details:
- net income and valuation ratios data:
APM - Final Profit|Projected Future Earnings Aptorum Group Limited|APM - Market Cap to Net Income Ratio|Future Price to Earnings Aptorum Group Ltd|APM - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptorum Group|APM - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Aptorum Group|APM - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months aptorumgroup.com|APM - Earnings per share trend in current year|Expected earnings per share growth for next year Aptorum Group Limited
Fundamental company valuation:Aptorum Group Limited
The Aptorum Group Limited (APM) business model is based on the monetization of R&D through the sale of molecule rights, which eliminates capital expenditures for production. This indicator reflects the consensus forecast for the compound annual growth rate of net profit, capturing the level of analyst confidence in future earnings. High volatility in the EPS growth prospects for the next fiscal year signals valuation uncertainty, increasing the risk of an erroneous entry into the asset.
Main competitors
Net earnings per share growth forecast for next year Haleon Group|KVUE: Expected earnings per share trend next year|Earnings growth forecast for next year VRNA|Earnings growth forecast for next year jyongbio.com (MENS)|Net earnings per share growth forecast for next year Ligand LGND|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share change forecast for next year|PRGO: Expected earnings per share growth for next year|Alvotech Biopharmaceuticals - Projected earnings per share increase next year|Liquidia Corporation (LQDA) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year glpg.com (GLPG)|Net earnings per share growth forecast for next year ANI Pharmaceuticals, Inc.|MNKD: Expected earnings per share trend next year|Expected earnings per share growth for next year AMPH (Amphastar)|Earnings growth forecast for next year Pacira Corp (PCRX)|Net earnings per share growth forecast for next year ARS Pharmaceuticals SPRY|TBPH - Expected earnings per share growth for next year|AQST: Expected earnings per share growth for next year|Expected earnings per share trend next year SCPH (scPharmaceuticals Inc.)|TECX: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Tonix Pharmaceuticals Holding TNXP|Net earnings per share growth forecast for next year SXT Pharmaceuticals|EPRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioHarvest Sciences Inc. (BHST)|EXOZ - Expected net earnings per share growth next year|Oramed Pharmaceuticals Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Entera Bio Ltd ENTX|HYFT - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ABVC|CPIX (Cumberland Pharmaceuticals Inc.) - Expected earnings per share growth for next year|Quantum BioPharma Ltd. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year FibroGen Corp|Net earnings per share growth forecast for next year TELO|Earnings growth forecast for next year RANI|Consensus forecast of earnings per share growth for next year synergychc.com|Net earnings per share growth forecast for next year Rallybio RLYB|LEXX - Expected earnings per share growth for next year|Pulmatrix Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Pheton Holdings Ltd PTHL|LYRA (Lyra Therapeutics, Inc.) - Expected earnings per share growth for next year|IBO: Projected earnings per share increase next year|TNFA (TNF Pharmaceuticals Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year cbdMD Corp YCBD|Earnings growth forecast for next year PRFX|altamiratherapeutics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year LIPO (Lipella Pharmaceuticals)|Earnings growth forecast for next year optinose.com OPTN|PIRS - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PROC|Petros (PTPI) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Qilian International Corp|Net earnings per share growth forecast for next year Acelyrin, Inc.|tffpharma.com - Net earnings per share change forecast for next year
